Capone, E.; Lamolinara, A.; Pastorino, F.; Gentile, R.; Ponziani, S.; Di Vittorio, G.; D’Agostino, D.; Bibbò, S.; Rossi, C.; Piccolo, E.;
et al. Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers 2020, 12, 2989.
https://doi.org/10.3390/cancers12102989
AMA Style
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D’Agostino D, Bibbò S, Rossi C, Piccolo E,
et al. Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers. 2020; 12(10):2989.
https://doi.org/10.3390/cancers12102989
Chicago/Turabian Style
Capone, Emily, Alessia Lamolinara, Fabio Pastorino, Roberta Gentile, Sara Ponziani, Giulia Di Vittorio, Daniela D’Agostino, Sandra Bibbò, Cosmo Rossi, Enza Piccolo,
and et al. 2020. "Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma" Cancers 12, no. 10: 2989.
https://doi.org/10.3390/cancers12102989
APA Style
Capone, E., Lamolinara, A., Pastorino, F., Gentile, R., Ponziani, S., Di Vittorio, G., D’Agostino, D., Bibbò, S., Rossi, C., Piccolo, E., Iacobelli, V., Lattanzio, R., Panella, V., Sallese, M., De Laurenzi, V., Giansanti, F., Sala, A., Iezzi, M., Ponzoni, M.,
... Sala, G.
(2020). Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers, 12(10), 2989.
https://doi.org/10.3390/cancers12102989
